Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Estrogen has many positive effects on neural tissue in experimental model systems, including stimulation of neurite growth and neurotransmitter synthesis and protection against diverse types of neural injury. In humans, estrogen treatment is reputed to protect against Alzheimer's disease. To investigate potential mediators of estrogen's action and determine whether selective estrogen receptor modulators (SERMs) such as tamoxifen have estrogen-like effects in the primate brain, we evaluated the expression of glucose transporters and insulin-like growth factor 1 (IGF1) and its receptor in the frontal cortex of ovariectomized rhesus monkeys. We treated one group for 3 days with vehicle, another with 17 beta estradiol (E2), and a third with tamoxifen. The expression of facilitative glucose transporters (Gluts) 1, 3, and 4 was investigated using in situ hybridization, immunohistochemistry, and immunoblot analysis. Gluts 3 and 4 were concentrated in cortical neurons and Glut1 in capillaries and glial cells. E2 treatment induced two- to fourfold increases in Glut3 and Glut4 mRNA levels and lesser but significant increases in Glut3 and 4 protein levels. E2 treatment induced an approximately 70% increase in parenchymal Glut1 mRNA levels, but did not appreciably affect vascular Glut1 gene expression. IGF1 and IGF1 receptor mRNAs were concentrated in cortical neurons in a distribution similar to Gluts 3 and 4. IGF1 mRNA levels were significantly increased in E2-treated animals but IGF1 receptor mRNA levels were not altered by hormone treatment. Tamoxifen increased cerebral cortical Glut3 and 4 mRNA levels, but did not affect Glut1, IGF1, or IGF1 receptor expression. This study provides novel data showing that Gluts 3 and 4 and IGF1 are coexpressed by primate cerebral cortical neurons, where their expression is enhanced by estrogen. These findings suggest that up-regulation of glucose transporter and IGF1 expression may contribute to estrogen's salutary effects on neural tissue. Tamoxifen, an antiestrogen at the breast, is shown to have estrogen-like effects on higher brain centers in the monkey, suggesting that some SERMs may share estrogen's neuroprotective potential for menopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estrogens and estrogen receptors regulate various aspects of glucose and lipid metabolism.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [114]
Citations
Cites
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
GROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838 · cited 1×
“Moreover, the IGF1 and insulin receptors are homologous, with ;85% identity in the intracellular, signal-transducing portion of the receptors (45, 46).”
BackgroundImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358 · cited 1×
“anabolic effects on neural tissue (4) are identical to”
BackgroundInterleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979
Research works printed but not linked: 3
- 10.1210/endo.133.6.8243275 · doi:10.1210/endo.133.6.8243275 · Paper page
- 10.1210/endo.135.5.7525251 · doi:10.1210/endo.135.5.7525251 · Paper page
- 10.1210/endo.132.4.8384986 · doi:10.1210/endo.132.4.8384986 · Paper page
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Estrogens regulate glucose/energy metabolism via the direct and indirect control of the expression of enzymes that are involved in this process, such as hexokinase (HK), phosphoglucoisomerase (PGI), phosphofructokinase (PFK), aldolase (AD), glyceraldehyde 3-phosphate dehydrogenase (GAPD), phosphoglycerate kinase (PK)…”
BackgroundGlucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558
“It was observed that 17beta-estradiol increased the expression of Glut1 in the BBB of ovarectomized female rats [373] and the expression of GLUT1, GLUT3, and GLUT4 in brain of ovarectomized female rhesus monkeys [63].”
BackgroundEstrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
“Glucose transporter-4 (GLUT-4) is also expressed on neuronal membranes, and is unique because its translocation from the cytoplasmic compartment to the cell membrane is regulated by insulin.”
InfluentialÅberg, N. D., Brywe, K. G., & Isgaard, J. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.22 · Cited by 387
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Brinton, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.003 · Cited by 385
“Bondy and colleagues found that IGF-1R mRNA was concentrated in cortical neurons in a distribution similar to Gluts 3 and 4 [ 41 ].”
InfluentialWalsh, A. J., Cook, R. S., Manning, H. C., Hicks, D. J., Lafontant, A., Arteaga, C. L., & Skala, M. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0527 · Cited by 316
“3), known oncogenic drivers of glycolytic metabolism in breast cancer cells (3, 8, 37, 38).”
Walsh, A. J., Cook, R. S., Sanders, M. E., Aurisicchio, L., Ciliberto, G., Arteaga, C. L., & Skala, M. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0663 · Cited by 312
“Cellular metabolism may provide biomarkers of early treatment response, because oncogenic drivers typically affect metabolic signaling (1, 2).”
Estrogen-induced plasticity from cells to circuits: predictions for cognitive function
Brinton, R. D. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.006 · Cited by 303
“primate brain [ 39 ] while also increasing glucose transport in the blood–brain barrier endothelium [40].”
BackgroundDing, F., Yao, J., Rettberg, J. R., Chen, S., & Brinton, R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079977 · Cited by 262
“Coincident with the decline in glucose uptake, GLUT3 expression and hexokinase activity, we observed an age dependent increase in phosphorylated PDH, a mechanism of PDH inactivation.”
BackgroundInfluentialOptical Redox Ratio Differentiates Breast Cancer Cell Lines Based on Estrogen Receptor Status
Ostrander, J. H., McMahon, C. M., Lem, S., Millon, S. R., Brown, J. Q., Seewaldt, V. L., & Ramanujam, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2572 · Cited by 190
“For example, estrogen exposure has been shown to increase the expression of a number of glucose transporter (GLUT) proteins (12, 15, 16).”
Chen, J.-Q., Brown, T. R., & Russo, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.03.009 · Cited by 190
“[70] observed that E2 treatment induced two- to four fold increases in Glut3 and Glut4 mRNA levels and lesser but significant increases in Glut3 and 4 protein levels in primate cerebral cortex.”
BackgroundInfluentialEstrogen receptors: new players in diabetes mellitus
Barros, R. P. A., Machado, U. F., & Gustafsson, J.-Å. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.004 · Cited by 183
The Multiple Roles of Estrogens and the Enzyme Aromatase
Boon, W. C., Chow, J. D. Y., & Simpson, E. R. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(08)81012-6 · Cited by 168
Brinton, R. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.003 · Cited by 155
“Bondy and colleagues found that IGF-1R mRNA was concentrated in cortical neurons in a distribution similar to Gluts 3 and 4 [43].”
BackgroundInfluentialWang, D.-Y., Fulthorpe, R., Liss, S. N., & Edwards, E. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0202 · Cited by 151
“1, bar b), including estrogen-induced gene 4 (E2IG4) (11), IGF binding protein 4 (IGFBP4) (7), 1,4-galactosyltransferase, polypeptide 1 (B4GALT1) (14), solute carrier family 2 member 1/glucose transporter 1 (SLC2A1/ GLUT1) (15, 16), and three fragments of X-box binding protein 1 (XBP1) (6, 7).”
BackgroundCentral Nervous System Imprinting of the G Protein Gsα and Its Role in Metabolic Regulation
Chen, M., Wang, J., Dickerson, K. E., Kelleher, J., Xie, T., Gupta, D., Lai, E. W., Pacak, K., Gavrilova, O., & Weinstein, L. S. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.004 · Cited by 133
“In situ hybridization of brain slices was performed as previously described (Cheng et al., 2001) using 118 bp sense and antisense RNA probes for Gsa exon 1 (coding nucleotides 5–122).”
Self-citationZhao, L., Yao, J., Mao, Z., Chen, S., Wang, Y., & Brinton, R. D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.010 · Cited by 124
Quesada, A., Romeo, H. E., & Micevych, P. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21358 · Cited by 118
“In addition, E2 can regulate the expression of IGF-1 and IGF-1R in neural tissue (Cardona-Gomez et al., 2001; Cheng et al., 2001; El-Bakri et al., 2004).”
BackgroundMoreira, P. I., Santos, M. S., Moreno, A. M., Seiça, R., & Oliveira, C. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1449 · Cited by 117
“Insulin-sensitive glucose transporters are found not only at the blood-brain barrier but also in glia expressing partially insulin-sensitive GLUT1 (4,5) and in some neurons expressing GLUT1 (4) and/or GLUT4 (6,7).”
BackgroundCardona‐Gómez, G. P., Méndez, P., DonCarlos, L. L., Azcoitia, Í., & García‐Segura, L. M. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00261-3 · Cited by 129
“Furthermore, estrogen increases in parallel the expression of glucose transporter and IGF-I in the primate cerebral cortex [42].”
BackgroundCardona‐Gómez, G. P., Méndez, P., & García‐Segura, L. M. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00449-7 · Cited by 109
Hormonal Agents for the Treatment of Depression Associated with the Menopause
Herson, M., & Kulkarni, J. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00962-x · Cited by 123
Estrogen Regulation of Mitochondrial Bioenergetics
Yao, J., & Brinton, R. D. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00010-6 · Cited by 88
“Later work by Bondy and colleagues confirmed E2 regulation of glucose transporter proteins and that regulation of glucose transporters occurs in neurons in the nonhuman primate brain (Cheng et al., 2001).”
BackgroundResultInfluentialGibbs, R. B., Gabor, R., Cox, T., & Johnson, D. A. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00118-5 · Cited by 96
“, 1995) and regional glucose utilization (Cheng et al., 2001; Rasgon et al., 2001).”
Xiuli, G., Geng, M., & Du, G. (2005) · Biochemical Genetics · doi:10.1007/s10528-005-1510-5 · Cited by 107
“ment with 17β estradiol (E2) induced a marked increase in parenchymal GLUT1 mRNA levels but did not appreciably affect vascular GLUT1 gene expression in the brain of ovariectomized rhesus monkeys (Cheng et al., 2001).”
BackgroundInsulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats
Moreira, P. I., Santos, M. S., Sena, C., Seiça, R., & Oliveira, C. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.017 · Cited by 88
“…glucose transporters are found not only at the blood–brain barrier, but also in glia expressing partially insulin-sensitive GLUT1 (Ngarmukos et al., 2001; Vannucci et al., 1997) and in some neurons expressing GLUT1 (Vannucci et al., 1997) or GLUT4 (Cheng et al., 2001; Choeiri et al., 2002).”
BackgroundOptical imaging of metabolism in HER2 overexpressing breast cancer cells
Walsh, A. J., Cook, R. S., Rexer, B. N., Arteaga, C. L., & Skala, M. C. (2011) · Biomedical Optics Express · doi:10.1364/boe.3.000075 · Cited by 90
Glucose transporter 3 in neuronal glucose metabolism: Health and diseases
Peng, W., Tan, C., Mo, L., Jiang, J., Zhou, W., Du, J., Zhou, X., Liu, X., & Chen, L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154869 · Cited by 98
Restructuring the neuronal stress response with anti-glucocorticoid gene delivery
Kaufer, D., Ogle, W. O., Pincus, Z., Clark, K., Nicholas, A. C., Dinkel, K., Dumas, T. C., Ferguson, D., Lee, A. L., Winters, M. A., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1296 · Cited by 84
“Many are receptor dependent and transcriptionally mediated, including upregulation of glucose transporter”
BackgroundStudd, J. W. W., & Nappi, R. E. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.651932 · Cited by 91
“Another neuroprotective activity of estrogen is the increase of glucose uptake and utilization by enhancing the expression of glucose transporter at the bloodbrain barrier and on the membranes of neurons [22,23].”
BackgroundHenderson, V. W., & Brinton, R. D. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82003-5 · Cited by 79
“This process of facilitated transport, which is mediated by specific glucose transporters and associated with an increase in insulin growth factor-1 expression, is modulated by estradiol (Cheng et al., 2001; Shi and Simpkins, 1997).”
BackgroundGlycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer
Rivenzon‐Segal, D., Boldin‐Adamsky, S., Seger, D., Seger, R., & Degani, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11387 · Cited by 80
Cheng, C. M., Kelley, B., Wang, J., Strauss, D., Eagles, D. A., & Bondy, C. A. (2003) · Endocrinology · doi:10.1210/en.2002-0057 · Cited by 83
“It is possible that GLUT3 expression was increased due to enhanced IGF activity in brain, as we have previously shown an association between increased IGF1R and increased GLUT3 expression in the monkey brain (31).”
BackgroundSelf-citationMehta, S. H., Dhandapani, K. M., De Sevilla, L. M., Webb, R. C., Mahesh, V. B., & Brann, D. W. (2003) · Neuroendocrinology · doi:10.1159/000068332 · Cited by 78
“Our finding that tamoxifen has estrogen-like neuroprotective effects in the brain adds to a growing literature demonstrating estrogen-like effects of tamoxifen in the regulation of glucose transporters and IGF-1 expression in the primate cerebral cortex [”
BackgroundGlucose transporter plasticity during memory processing
Choeiri, C., Staines, W. A., Miki, T., Seino, S., & Messier, C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.011 · Cited by 84
Steroids and the Blood–Brain Barrier
WITT, K. A., & Sandoval, K. E. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.018 · Cited by 80
Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
C. Correia, S., X. Santos, R., Cardoso, S., Carvalho, C., S. Santos, M., R. Oliveira, C., & I. Moreira, P. (2010) · Current Aging Sciencee · doi:10.2174/1874609811003020113 · Cited by 67
Wang, Y., Mishra, A., & Brinton, R. D. (2020) · F1000Research · doi:10.12688/f1000research.21599.1 · Cited by 61
Zhu, J., Zhou, Y., Jin, B., & Shu, J. (2023) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231199359 · Cited by 84
Tamási, V., Petschner, P., Adori, C., Kirilly, E., Ando, R. D., Tothfalusi, L., Juhasz, G., & Bagdy, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113662 · Cited by 61
“modulates insulin sensitivity; (ii) Slc2a4 (Facilitaded glucose transporter, GLUT4), which has cytoplasmic expression in the neurons, but hormones (insulin or leptin) could translocate it to the plasma membrane [102, 103]; (iii) Ucp3 (Uncoupling protein 3), which prevents glucose-induced transient mitochondrial membra…”
BackgroundMartino, G., Catalano, A., Agostino, R. M., Bellone, F., Morabito, N., Lasco, C. G., Vicario, C. M., Schwarz, P., & Feldt-Rasmussen, U. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230681 · Cited by 61
Neuroprotective Effects of Estrogen and Tamoxifen In Vitro: A Facilitative Role for Glia?
Dhandapani, K. M., & Brann, D. W. (2003) · Endocrine · doi:10.1385/endo:21:1:59 · Cited by 62
Cellular Strategies of Estrogen-Mediated Neuroprotection During Brain Development
Kajta, M., & Beyer, C. (2003) · Endocrine · doi:10.1385/endo:21:1:3 · Cited by 54
Nashiro, K., Guevara-Aguirre, J., Braskie, M. N., Hafzalla, G. W., Velasco, R., Balasubramanian, P., Wei, M., Thompson, P. M., Mather, M., Nelson, M. D., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1929-16.2016 · Cited by 51
“First, IGF-1 and IGFR-1 can be found in primate frontal cortex (Cheng et al., 2001; Xie et al., 2013).”
BackgroundEstradiol alters transcription factor gene expression in primate prefrontal cortex
Wang, J., Cheng, C. M., Zhou, J., Smith, A., Weickert, C. S., Perlman, W. R., Becker, K. G., Powell, D., & Bondy, C. A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20076 · Cited by 47
“…Hou et al., 2000; Gendron et al., 2001) and hence estrogen-induced suppression of E2F1 expression, together with augmentation of IGF1 expression (Cheng et al., 2001), which is an important antiapoptotic factor for neurons (Feldman et al., 1997), may contribute to estrogen’s neuroprotective…”
BackgroundMethodSelf-citationMcAsey, M. E., Cady, C., Jackson, L. M., Li, M., Randall, S., Nathan, B. P., & Struble, R. G. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.008 · Cited by 49
Treatment with tamoxifen reduces hypoxic–ischemic brain injury in neonatal rats
Feng, Y., Fratkins, J. D., & LeBlanc, M. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.048 · Cited by 46
Wise, D. D., Felker, A., & Stahl, S. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013742 · Cited by 42
Fehsel, K., & Christl, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101592 · Cited by 47
Bondy, C. A., & Cheng, C. M. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51006-0 · Cited by 47
Self-citationDeclarative Querying for Biological Sequences
Tata, S., Friedman, J. S., & Swaroop, A. (2006) · IEEE International Conference on Data Engineering (ICDE) · doi:10.1109/icde.2006.47 · Cited by 40
“SLC2A2, is a GLUT family member which has many members known to be augmented by estrogen [ 29 ].”
BackgroundGuo, J., Du, C., Shan, L., Zhu, H., Xue, B., Qian, Z., Achilefu, S. A., & Gu, Y. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.496 · Cited by 40
Dieli‐Conwright, C. M., Spektor, T. M., Rice, J. C., & Todd Schroeder, E. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01997.x · Cited by 39
“These proteins are influenced by oestrogen and SERMs in human tissues including skeletal muscle (Barros et al. 2006, Enns and Tiidus 2008, Enns et al. 2008), breast tissue (Medina et al. 2003) and the brain (Cheng et al. 2001).”
BackgroundThe insulin-like growth factor system and the fetal brain: Effects of poor maternal nutrition
McDonald, T. J., Nijland, M. J., & Nathanielsz, P. W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9044-2 · Cited by 37
“This observation suggests that one of the mechanisms by which estrogen treatment is neuroprotective is via an influence on IGF-I regulation of GLUT expression in primates [128].”
BackgroundGlucose Transporters in Sex Steroid Hormone Related Cancer
Nualart, F., García, M. D. L. Á., Medina, R. A., & Owen, G. I. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043928 · Cited by 34
Wong, J., & Weickert, C. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013243 · Cited by 37
Morán, J., Garrido, P., Alonso, A., Cabello, E., & González, C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.010 · Cited by 34
Women's higher brain metabolic rate compensates for early Alzheimer's pathology
Sundermann, E. E., Maki, P. M., Reddy, S., Bondi, M. W., Biegon, A. R., & Initiative, A. D. N. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12121 · Cited by 41
“36 In vivo studies demonstrate estradiol modulation of glucose transporter 1 (GLUT-1) protein and messenger RNA (mRNA) expression in blood-brain barrier endothelium.”
D’Astous, M., Steinmetz, K. R. M., Dluzen, D. E., & Paolo, T. D. (2005) · Neuroendocrinology · doi:10.1159/000091206 · Cited by 34
Anorexia nervosa and estrogen: Current status of the hypothesis
Young, J. K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.015 · Cited by 29
“Estrogens increase the sensitivity of the brain to satiety factors such as leptin, glucose, and cholecystokinin (Butera et al., 1996; Cheng et al., 2001; Clegg et al., 2006; Gao et al., 2007; Musatov et al., 2007; Thammacharoen et al., 2008; Young et al., 1978a,b).”
BackgroundHenderson, V. W. (2006) · The Neurologist · doi:10.1097/01.nrl.0000215750.52786.b1 · Cited by 36
Hamilton, R. T., Rettberg, J. R., Mao, Z., To, J., Zhao, L., Appt, S. E., Register, T. C., Kaplan, J. R., & Brinton, R. D. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.029 · Cited by 30
“Complex IV expression was not significantly affected by hormone treatment (F2, 23 = 0.44, p 0.65) (Figure 4D), but there was a slight trend towards increased expression in NHPs treated with 17β-estradiol compared to controls (p 0.35).”
BackgroundInfluentialHigh-throughput measurements of the optical redox ratio using a commercial microplate reader
Cannon, T. M., Shah, A. T., Walsh, A. J., & Skala, M. C. (2015) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.1.010503 · Cited by 29
“which is related to chemotherapeutic response, HER2 expression and ER expression.(8,9) Cancer cells exhibit the Warburg effect and preferentially undergo aerobic glycolysis.”
BackgroundLovekamp-Swan, T., Glendenning, M. L., & Schreihofer, D. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.026 · Cited by 28
Estrogen Regulation of Neurotransmitter and Growth Factor Signaling in the Brain
Etgen, A. M., & García‐Segura, L. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00044-4 · Cited by 28
Korol, D. L., & Wang, W. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.11.022 · Cited by 30
Non‐genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells
Boscaro, C., Carotti, M., Albiero, M., Trenti, A., Fadini, G. P., Trevisi, L., Sandonà, D., Cignarella, A., & Bolego, C. (2020) · The FASEB Journal · doi:10.1096/fj.202001130r · Cited by 28
Wang, D., McKague, B., Liss, S. N., & Edwards, E. A. (2004) · Environmental Science & Technology · doi:10.1021/es049235r · Cited by 26
Chronic Estradiol Treatment Improves Brain Homeostasis during Aging in Female Rats
Alonso, A., Moreno, M., Ordóñez, P., Fernandez‐Ruiz, R., Pérez, C., Dı́az, F., Navarro, A., Tolivia, J., & González, C. (2007) · Endocrinology · doi:10.1210/en.2007-0627 · Cited by 24
Li, X., Han, H., Hou, R., Wei, L., Wang, G., Li, C., & Li, D. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1298-y · Cited by 22
A practical nutritional guide for the management of sleep disturbances in menopause
Laudisio, D., Barrea, L., Pugliese, G., Aprano, S., Castellucci, B., Savastano, S., Colao, A., & Muscogiuri, G. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1851658 · Cited by 26
Kirshner, Z. Z., Yao, J. K., Li, J., Long, T., Nelson, D., & Gibbs, R. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117975 · Cited by 24
Arjmand, S., Ilaghi, M., Sisakht, A. K., Guldager, M. B., Wegener, G., Landau, A. M., & GJEDDE, A. H. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14035 · Cited by 23
“107,111 E2 raises the expression of IGF-1 in the brain, 107 and IGF-1 can regulate the recruitment of Glut transporters in the brain, 112,113 suggesting that the modulation of glucose metabolism by means of ERs may be influenced by IGF-1 levels as well.”
The Effect of Dietary Intake on Hot Flashes in Menopausal Women
Dormire, S. L., & Howharn, C. (2007) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2007.00142.x · Cited by 23
Psychoactive drugs affect glucose transport and the regulation of glucose metabolism
Dwyer, D. S., Ardizzone, T. D., & Bradley, R. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51015-1 · Cited by 18
Seo, H.-S., & Leclercq, G. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00175-3 · Cited by 18
Stanley, J. A., Aruldhas, M. M., Yuvaraju, P. B., Banu, S. K., Jaganathan, A., Neelamohan, R., Annapoorna, K., & Jayaraman, G. (2010) · Steroids · doi:10.1016/j.steroids.2010.06.009 · Cited by 17
Navarro, A., del Valle, E., Ordóñez, C., Martínez‐Pinilla, E., Pérez, C., Alonso, A., González, C., & Tolivia, J. (2012) · AGE · doi:10.1007/s11357-012-9415-9 · Cited by 17
“…with the consequent loss of ovaric estrogens, aggravates the effect of normal aging in cognitive decline and compared to hormone treated animals (Cheng et al. 2001; Oge et al. 2003; Stirone et al. 2003), raising the idea that these sexual hormones exert neuroprotective effects even once…”
BackgroundMorán, J., Garrido, P., Cabello, E., Alonso, A., & González, C. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.018 · Cited by 16
“In this manner, estrogen treatment increases both cerebral metabolic activity (Nilsen et al., 2007), and brain glucose utilization (Cheng et al., 2001; Namba and Sokoloff, 1984).”
InfluentialThe Potential Role of Glucose Transport Changes in Hot Flash Physiology: A Hypothesis
Dormire, S. L. (2008) · Biological Research For Nursing · doi:10.1177/1099800408324558 · Cited by 14
Roy, V. K., & Krishna, A. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.05.016 · Cited by 15
“In the primate adrenal cortex, estradiol (E2) has been reported to increase GLUT-1, 3 and 4 expression levels, while tamoxifen increases GLUT-3 and 4 expression levels (Cheng et al., 2001).”
BackgroundSalinero, A. E., Abi‐Ghanem, C., Venkataganesh, H., Sura, A., Smith, R. M., Thrasher, C. A., Kelly, R. D., Hatcher, K. M., NyBlom, V., Shamlian, V., et al. (2024) · Hormones and Behavior · doi:10.1016/j.yhbeh.2024.105594 · Cited by 15
Cushman, T. T., Kim, N. N., Hoyt, R. F., & Traish, A. M. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.023 · Cited by 12
Ni, Y., Zhou, Y., Zhou, M., & Zhang, L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.07.041 · Cited by 12
Li, J., Wang, Y., Wang, L., Hao, D., Li, P., Su, M., Zhao, Z., Liu, T., Tai, L., Lu, J., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80952 · Cited by 11
“Estrogen has been shown to increase intracellular NADH levels in different tissues due to its ability to increase glycolysis activity [56-59].”
BackgroundMolecular landscape of the overlap between Alzheimer’s disease and somatic insulin-related diseases
Ruisch, I. H., Widomska, J., Witte, W. D., Mota, N. R., Fanelli, G., van Gils, V., Jansen, W. J., Vos, S. J. B., Fóthi, Á., Barta, C., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01609-2 · Cited by 11
Anorexia Nervosa and Estrogen Receptors
Ramoz, N., Versini, A., & Gorwood, P. A. P. M. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-410473-0.00006-4 · Cited by 15
Estrogen Regulation of Neurotransmitter and Growth Factor Signaling in the Brain
Etgen, A. M., & García‐Segura, L. M. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00033-4 · Cited by 11
Effects of androgen and oestrogen on IGF pathways controlling phallus growth
Chen, Y., Yu, H., Pask, A. J., Fujiyama, A., Suzuki, Y., Sugano, S., Shaw, G., & Renfree, M. B. (2018) · Reproduction · doi:10.1530/rep-18-0416 · Cited by 8
Harrell, C. S., Burgado, J., Kelly, S. D., & Neigh, G. N. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12139 · Cited by 9
“Increased cerebral glucose uptake, mediated either by natural fluctuations in ovarian hormone (17) or exogenous administration of ovarian hormones (49), may be mediated by changes in hormonally-dependent GLUT expression (Figs 4, 5 and 6) (20,21,50).”
BackgroundDiabetes Attenuates Female Genital Sexual Arousal Response via Disruption of Estrogen Action
Traish, A. M., Cushman, T. T., Hoyt, R. F., & Kim, N. N. (2009) · Korean journal of urology · doi:10.4111/kju.2009.50.3.211 · Cited by 8
“GLUT4 expression has been shown to be upregulated with estrogen treatment in primate cerebral cortex.(88) ERα null mice showed reduced GLUT4 expression in skeletal muscle.”
BackgroundPotential Age-Dependent Effects of Estrogen on Neural Injury
León, R. L., Huber, J. D., & Rosen, C. L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.057 · Cited by 11
Jensen, V. F. H., Mølck, A., Chapman, M., Alifrangis, L. H., Andersen, L. F., Lykkesfeldt, J., & Bøgh, I. B. (2017) · International Journal of Endocrinology · doi:10.1155/2017/7861236 · Cited by 9
“In agreement with this, higher GLUT1 mRNA levels have been shown in adipocytes from females compared to those frommales inmice [53], seemingly mediated through sex steroids, which is further corroborated by a study in female estradiol-treated rhesus monkeys [54].”
Martier, A. T., Maurice, Y. V., Conrad, K. M., Carlino, D. A., Mauvais‐Jarvis, F., & Mondrinos, M. J. (2025) · Communications Biology · doi:10.1038/s42003-025-08822-1 · Cited by 13
Liu, T., Nath, K., Liu, W., Zhou, R., & Chen, I. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3342 · Cited by 7
Use of the Primate Model in Research
Morton William, R., Kyes Kelly, B., Kyes, R. C., Swindler, D. R., & Swindler, K. (2005) · Elsevier eBooks · doi:10.1016/b978-012080261-6/50024-6 · Cited by 5
DHA (omega-3 fatty acid) and estradiol: key roles in regional cerebral glucose uptake
Majou, D., & Dermenghem, A.-L. (2023) · OCL · doi:10.1051/ocl/2023023 · Cited by 4
Kalimon, O. J., Vekaria, H. J., Prajapati, P., Short, S. L., Hubbard, W. B., & Sullivan, P. G. (2024) · Life · doi:10.3390/life14080961 · Cited by 7
Mohammed, S. N., Direksunthorn, T., Zwamel, A. H., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Naidu, K. S., Ahmad, I. S., & Ahmed, J. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05338-x · Cited by 3
The Role of Sex Steroids in Alzheimer's Disease: Prevention and Treatment
Henderson, V. W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50029-6 · Cited by 2
Metadata
- Authors
- CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 15
- Issue
- 6
- Pages
- 907-915
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2135078756
- Cited by
- 115
- References
- 110
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 8 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 9 · 2012: 5
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- estrogen, glucose transporters, insulin-like growth factor I, IGF-1 receptor, tamoxifen, selective estrogen receptor modulators, estradiol, frontal cortex, rhesus monkeys, GLUT3, GLUT4, GLUT1, neuroprotection, menopause, Alzheimer's disease
- MeSH terms
- Animals, Cerebral Cortex, Estradiol, Female, Insulin-Like Growth Factor I, Macaca mulatta, Monosaccharide Transport Proteins, Muscle Proteins, Nerve Tissue Proteins, RNA, Messenger, Tamoxifen, Gene Expression, Receptor, IGF Type 1, Antineoplastic Agents, Hormonal, Glucose Transporter Type 3, Glucose Transporter Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.